Related Experiment Video
Updated: Jul 14, 2026

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
Published on: June 10, 2020
Examination of an inducible expression system for limiting iron availability during Chlamydia trachomatis infection
Brian D Dill1, Jane E Raulston
1Department of Microbiology, Box 70579, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614-0579, USA. bddill@yahoo.com
Abstract:
The obligate intracellular bacterium Chlamydia trachomatis requires iron in order to complete its developmental cycle. Addition of an iron-chelating drug, Desferal (deferoxamine mesylate), to infected cell culture causes Chlamydia to enter persistence. Here, we explore the ability of a stably-transfected cell line with inducible over-expression of the eukaryotic iron efflux protein ferroportin to starve C. trachomatis serovar E for iron. Ferroportin-induced iron removal is perhaps a more direct method of removing iron from the intracellular compartment versus exposure to an exogenous chemical chelator. Following induction, ferroportin-green fluorescent protein (Fpn-GFP) was detected in the plasma membrane, and cells expressing Fpn-GFP remained viable throughout the timescale required for Chlamydia to complete its developmental cycle. Following Fpn-GFP induction in infected cells, chlamydial infectivity remained unchanged, indicating chlamydiae were not in persistence. Ferritin levels indicate only a small decrease in cellular iron following Fpn-GFP expression relative to cultures exposed to Desferal. These data indicate that expression of Fpn-GFP in chlamydiae-infected cells is not capable of reducing iron below the threshold concentration needed to cause chlamydiae to enter persistence.
Insights
Overexpressing ferroportin in host cells did not induce Chlamydia trachomatis persistence, unlike iron-chelating drugs. This suggests ferroportin-mediated iron reduction is insufficient to starve the bacteria.
Area of Science:
- Microbiology
- Cell Biology
- Biochemistry
Background:
- Chlamydia trachomatis requires iron for its life cycle.
- Iron chelation with Desferal induces bacterial persistence.
- Ferroportin is a eukaryotic iron efflux protein.
Purpose of the Study:
- To investigate if inducible ferroportin overexpression can starve Chlamydia trachomatis for iron.
- To compare ferroportin-mediated iron reduction with Desferal treatment.
Main Methods:
- Stable transfection of a cell line for inducible ferroportin-green fluorescent protein (Fpn-GFP) expression.
- Monitoring Fpn-GFP localization and cell viability.
- Assessing Chlamydia trachomatis infectivity and ferritin levels.
Main Results:
- Fpn-GFP was detected in the plasma membrane, and cells remained viable.
- Chlamydial infectivity was unchanged, indicating no induced persistence.
- Cellular iron reduction by Fpn-GFP was minimal compared to Desferal.
Conclusions:
- Inducible ferroportin expression does not reduce intracellular iron sufficiently to induce Chlamydia trachomatis persistence.
- Ferroportin-mediated iron efflux is less effective than Desferal in starving the bacteria.
More Related Videos
07:26Metal-Limited Growth of Neisseria gonorrhoeae for Characterization of Metal-Responsive Genes and Metal Acquisition from Host Ligands
Published on: March 4, 2020
08:51Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015